Saba Radhi, MD
Medical Oncology · Gilbert, AZNPI 1851583751
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $891 of the $1,108 with a category attached, or 80.5%. It is spread thinly across 19 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $532 and has fallen 69.1% since, to $165 in 2025. That places this record below the midpoint for medical oncology clinicians in AZ, where the typical reported total is $8,518.
Across 32 payments — averaging $34.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$150
- Lilly USA, LLC$147
- Regeneron Healthcare Solutions, Inc.$122
- Daiichi Sankyo Inc.$117
- Johnson & Johnson$117
- Astellas Pharma US Inc$99
- plus $355 from 13 others
Across 63 payments — averaging $8555.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$219K
- Merck$203K
- Genentech, Inc.$100K
- Incyte Corporation$17K
What the payments were for
- Food & beverage$89180%
- Education$21620%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 1 | $150 |
| Lilly USA, LLC | 3 | $147 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Daiichi Sankyo Inc. | 5 | $117 |
| Johnson & Johnson | 1 | $117 |
| Astellas Pharma US Inc | 1 | $99 |
| AbbVie | 4 | $86 |
| Merck | 3 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| Puma Biotechnology, Inc. | 2 | $32 |
| Caris MPI, Inc. | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Novocure Inc. | 1 | $19 |
| Springworks Therapeutics, Inc. | 1 | $19 |
| Sanofi | 1 | $15 |
| Tempus AI, Inc | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,108 in reported general payments places this provider in the 25th percentile of 59 medical oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErivedgeVismodegib | 27 | $354,956 |
| XalkoriCrizotinib | 11 | $286,666 |
| MekinistTrametinib Dimethyl Sulfoxide | 15 | $230,969 |
| TafinlarDabrafenib Mesylate | 15 | $203,618 |
| Ondansetron Hcl | 75 | $1,794 |
| Dexamethasone | 41 | $286 |
| Oxycodone Hcl | 13 | $254 |
| Potassium Chloride | 26 | $218 |
| Tramadol Hcl | 30 | $174 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 12 | $140 |
| Prednisone | 21 | $47 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Gilbert
- Fade MahmoudGilbert$14K
- Isaac BowmanGilbert$14K
- Sumeet MendoncaGilbert$12K
- Christina GomezGilbert$7K
- Zachary YeungGilbert$1K
- Bryan WongGilbert$238
- Jason SalganickPhoenix$1.6M
- Roopesh KantalaMesa$491K
- Nazish AhmadGlendale$205K
- Daniel von HoffScottsdale$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.